TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
607
|
684
|
1,078 |
| Financial expenses |
0
|
47
|
0 |
| Earnings before taxes |
73
|
61
|
388 |
| EBITDA |
-4
|
107
|
102 |
| Total assets |
3,143
|
3,207
|
3,553 |
| Current assets |
400
|
290
|
333 |
| Current liabilities |
272
|
173
|
302 |
| Equity capital |
2,738
|
2,868
|
3,029 |
| - share capital |
100
|
99
|
97 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
87.1%
|
89.4%
|
85.3% |
| Turnover per employee |
607
|
684
|
1,078 |
| Profit as a percentage of turnover |
12.0%
|
8.9%
|
36.0% |
| Return on assets (ROA) |
2.3%
|
3.4%
|
10.9% |
| Current ratio |
147.1%
|
167.6%
|
110.3% |
| Return on equity (ROE) |
2.7%
|
2.1%
|
12.8% |
| Change turnover |
-86
|
-417
|
34 |
| Change turnover % |
-12%
|
-38%
|
3% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.